WO2023088394A3 - New crystal forms of lurbinectedin and preparation thereof - Google Patents

New crystal forms of lurbinectedin and preparation thereof Download PDF

Info

Publication number
WO2023088394A3
WO2023088394A3 PCT/CN2022/132675 CN2022132675W WO2023088394A3 WO 2023088394 A3 WO2023088394 A3 WO 2023088394A3 CN 2022132675 W CN2022132675 W CN 2022132675W WO 2023088394 A3 WO2023088394 A3 WO 2023088394A3
Authority
WO
WIPO (PCT)
Prior art keywords
degrees
lurbinectedin
preparation
new crystal
crystal forms
Prior art date
Application number
PCT/CN2022/132675
Other languages
French (fr)
Chinese (zh)
Other versions
WO2023088394A2 (en
Inventor
陆彬文
张夏衡
邱小龙
刘文博
徐涛
张金凯
赵恒�
王虎
胡林
邹平
Original Assignee
江苏慧聚药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江苏慧聚药业股份有限公司 filed Critical 江苏慧聚药业股份有限公司
Publication of WO2023088394A2 publication Critical patent/WO2023088394A2/en
Publication of WO2023088394A3 publication Critical patent/WO2023088394A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Abstract

A new crystal form C and a new crystal form D of Lurbinectedin; an XRPD spectrum of crystal form C has characteristic Bragg angles at 4.0 degrees, 7.8 degrees, 10.1 degrees, 11.9 degrees, 18.2 degrees and 25.4 degrees; and an XRPD spectrum of crystal form D has characteristic Bragg angles at 4.7 degrees, 7.9 degrees, 9.4 degrees, 11.9 degrees, 13.0 degrees, 16.8 degrees, 20.3 degrees, 24.6 degrees and 25.5 degrees.
PCT/CN2022/132675 2021-11-19 2022-11-17 New crystal forms of lurbinectedin and preparation thereof WO2023088394A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111398172.5A CN115246846A (en) 2021-11-19 2021-11-19 New crystal form of rubitinid and preparation thereof
CN202111398172.5 2021-11-19

Publications (2)

Publication Number Publication Date
WO2023088394A2 WO2023088394A2 (en) 2023-05-25
WO2023088394A3 true WO2023088394A3 (en) 2023-09-21

Family

ID=83698861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/132675 WO2023088394A2 (en) 2021-11-19 2022-11-17 New crystal forms of lurbinectedin and preparation thereof

Country Status (2)

Country Link
CN (1) CN115246846A (en)
WO (1) WO2023088394A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115246846A (en) * 2021-11-19 2022-10-28 江苏慧聚药业股份有限公司 New crystal form of rubitinid and preparation thereof
CN115304619A (en) * 2022-04-08 2022-11-08 上海皓元医药股份有限公司 Crystal form of rubitinid and preparation method thereof
CN114940682A (en) * 2022-05-18 2022-08-26 博瑞制药(苏州)有限公司 Crystal form of ribitdine, preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1564822A (en) * 2001-08-07 2005-01-12 法马马有限公司 Antitumoral analogs
WO2012062920A1 (en) * 2010-11-12 2012-05-18 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
WO2021099635A1 (en) * 2019-11-21 2021-05-27 Pharma Mar, S.A. New solid state form of lurbinectedin
CN115246846A (en) * 2021-11-19 2022-10-28 江苏慧聚药业股份有限公司 New crystal form of rubitinid and preparation thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1564822A (en) * 2001-08-07 2005-01-12 法马马有限公司 Antitumoral analogs
WO2012062920A1 (en) * 2010-11-12 2012-05-18 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
WO2021099635A1 (en) * 2019-11-21 2021-05-27 Pharma Mar, S.A. New solid state form of lurbinectedin
CN115246846A (en) * 2021-11-19 2022-10-28 江苏慧聚药业股份有限公司 New crystal form of rubitinid and preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEIMING HE; ZHIGAO ZHANG; DAWEI MA: "A Scalable Total Synthesis of the Antitumor Agents Et‐743 and Lurbinectedin", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, VERLAG CHEMIE, HOBOKEN, USA, vol. 58, no. 12, 14 February 2019 (2019-02-14), Hoboken, USA, pages 3972 - 3975, XP072095926, ISSN: 1433-7851, DOI: 10.1002/anie.201900035 *

Also Published As

Publication number Publication date
CN115246846A (en) 2022-10-28
WO2023088394A2 (en) 2023-05-25

Similar Documents

Publication Publication Date Title
WO2023088394A3 (en) New crystal forms of lurbinectedin and preparation thereof
USD866536S1 (en) Antenna
USD875721S1 (en) Antenna
USD909352S1 (en) Antenna
USD909353S1 (en) Antenna
USD896795S1 (en) Antenna
USD874448S1 (en) Antenna
USD895587S1 (en) Antenna
USD907015S1 (en) Antenna
CA3155889A1 (en) Hydrophobic polyimide aerogels
AU2020330570A8 (en) Process of making CFTR modulators
USD954691S1 (en) Antenna
WO2019178191A8 (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors
ZA202207729B (en) Solid state form of pyroxasulfone
EP3840756A4 (en) Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one
EP3887368A4 (en) 3/4-((2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzamide derivative compounds
WO2005092310A3 (en) Chemically stable compositions of 4-hydroxy tamoxifen
USD858491S1 (en) Antenna
EP3774787A4 (en) A compound, a reaction product of said compound and production methods thereof
USD944780S1 (en) Antenna
USD895586S1 (en) Antenna
WO2019078653A3 (en) Modified conjugated diene-based polymer and method for preparing same
EP3971181A4 (en) 3-aryloxyl-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof
WO2020210174A3 (en) Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same
USD819609S1 (en) Antenna inlay